Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFNα in patients with metastatic melanoma

✍ Scribed by de Gast, G C; Batchelor, D; Kersten, M J; Vyth-Dreese, F A; Sein, J; van de Kasteele, W F; Nooijen, W J; Nieweg, O E; Waal, M A de; Boogerd, W

• Book ID: 109997459
• Publisher: Nature Publishing Group
• Year: 2003
• Tongue: English
• Weight: 119 KB
• Volume: 88
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/sj.bjc.6600717